Cardiac failure chronic+1
Not recruitingStudy on the Safety of Starting Vericiguat at 5 mg in Patients with Chronic Heart Failure with Reduced Ejection Fraction
Italy- Participants:18–64 years · 65+ years
- Substances:Vericiguat
- Sponsor:Bayer AG
Rare diseases
Investigational molecules
Locations
Back to Italy585 clinical trials in Pavia, Italy across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on heart failure prevention and innovative treatments for cardiac conditions, including research on TTR amyloidosis and specialized therapies for pulmonary hypertension.
Clinical trials evaluating new therapeutic approaches for cardiovascular complications and heart rhythm disorders.
Studies investigating treatments for acute ischemic stroke and progressive neurological conditions, with particular focus on improving patient outcomes and functional recovery.
Advanced research exploring innovative therapeutic approaches for various neurological conditions.
Research targeting chronic spontaneous urticaria, various forms of arthritis, and systemic autoimmune conditions affecting multiple organ systems.
Evaluation of novel therapies aimed at managing inflammatory responses and improving quality of life.
Comprehensive studies on chronic obstructive pulmonary disease and bronchiectasis, focusing on exacerbation prevention and symptom management.
Investigation of innovative therapeutic approaches for chronic respiratory conditions.
Advanced research in multiple myeloma and related blood disorders, including chronic myeloid leukemia and myelodysplastic syndromes.
Development of targeted therapies for various hematological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.